Jing Si Herbal Tea in the Treatment of Dyspeptic Symptoms
NCT05948215 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2023-07-17
Summary
Dyspepsia refers to chronic or recurrent upper gastrointestinal symptoms. According to the Rome IV criteria, functional dyspepsia (FD) symptoms included meal-related fullness, early satiation, epigastric pain or burning which are unexplained after routine investigation. FD causes substantial psychophysical burden because of its unknown etiology and high prevalence. Although FD is currently associated with local inflammation of the gastrointestinal tract and microbiota alteration, current available treatments for FD are of limited effectiveness. In view of this, many studies have applied Chinese herbal medicine in FD and achieved some therapeutic benefit. The Jing Si Herbal Tea composed of eight native Taiwanese herbs (wormwood, hickory grass, Ophiopogon japonicus, houttuynia cordata, platycodon, licorice, perilla leaves, chrysanthemum) has obtained a special export license from the Ministry of Health and Welfare. The Jing Si Herbal Tea also has been registered in clinical trials as a complementary treatment for COVID-19. The preliminary data demonstrated that the Jing Si Herbal Tea may improve gastrointestinal symptoms and anxiety in patients with COVID-19. Therefore, this study aims to investigate the impact of the Jing Si Herbal Tea on psychophysical burden and metabolites of microbiota in patients with FD through a double-blind randomized manner.
Conditions
- Functional Gastrointestinal Disorders
- Healthy Subjects
Interventions
- DIETARY_SUPPLEMENT
-
Jing Si Herbal Tea Liquid Packet
The preliminary data demonstrated that the Jing Si Herbal Tea Liquid Packet may improve gastrointestinal symptoms and anxiety in patients with Coronavirus disease 2019(COVID-19). Therefore,this study aims to investigate the impact of the Jing Si Herbal Tea Liquid Packet on psychophysical burden and metabolites of microbiota in patients with FD through a double-blind randomized manner.
- DIETARY_SUPPLEMENT
-
Jing Si Herbal Tea Liquid Packet Placebo
Compared with the improvement effect of Jing Si Herbal Tea Liquid Packet, to avoid participants thinking that the improvement is due to psychological effects.
Sponsors & Collaborators
-
Buddhist Tzu Chi General Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
International Clinical Study of Zhizhu Kuanzhong Capsule
NCT03825692 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Functional Dyspepsia With Acupuncture
NCT00786214 ·Status: COMPLETED ·Phase: NA
-
Traditional Chinese Medicine Xiang-sha-liu-jun Granules in Patients With Postprandial Distress Syndrome(PDS)
NCT02762136 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Heterogeneous Distribution of Health Literacy and Emotional State on Patients With Functional Dyspepsia.
NCT02737683 ·Status: UNKNOWN
-
Zhizhu Kuanzhong Capsule for Patients With Functional Dyspepsia-Postprandial Distress Syndrome
NCT04380233 ·Status: UNKNOWN ·Phase: NA
-
Effects of Exercise on Functional Dyspepsia Based on Rome IV
NCT04540549 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study on Post Evaluation After Listing of Qizhi Weitong Granules
NCT03149393 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia
NCT03617016 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Functional Dyspepsia With Genuine Regional Rhizoma Atractylodis
NCT03173183 ·Status: UNKNOWN ·Phase: NA
-
Stigma and Efficacy of Zhizhu Kuanzhong Capsules
NCT05107999 ·Status: UNKNOWN ·Phase: NA
-
Correlation Study of Atrophic Gastritis and Dyspepsia Symptoms
NCT07250308 ·Status: RECRUITING
-
Acupuncture for Patients With Function Dyspepsia
NCT01671670 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Zypan Functional Dyspepsia
NCT06320379 ·Status: RECRUITING ·Phase: NA
-
Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers
NCT00153712 ·Status: COMPLETED
-
Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment
NCT05513040 ·Status: RECRUITING
-
Study on the Rule and Mechanism of Treating Functional Gastrointestinal Diseases From the Perspective of Liver and Spleen
NCT04454996 ·Status: UNKNOWN ·Phase: PHASE4
-
Randomized Controlled Trial of Acupuncture for Functional Dyspepsia
NCT00599677 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia
NCT05199441 ·Status: COMPLETED ·Phase: PHASE4
-
Gastric Activity and Gastrointestinal Peptides in Patients With Functional Dyspepsia
NCT02113527 ·Status: COMPLETED
-
Acupuncture of Different Treatment Frequency on Improving Quality of Life in Patients With Functional Dyspepsia
NCT04548011 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Efficacy of Electroacupuncture in the Treatment of Functional Dyspepsia
NCT06618911 ·Status: RECRUITING ·Phase: NA
-
Comparative Study of Epigastric Pain Syndrome and Postprandial Distress Syndrome
NCT00673972 ·Status: WITHDRAWN ·Phase: PHASE4
-
To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia
NCT00761358 ·Status: COMPLETED ·Phase: PHASE3
-
Association of Functional Dyspepsia Symptom Diary Score and Other Scores Related to Functional Dyspepsia and Its Severity
NCT04953975 ·Status: COMPLETED
-
Primary Care dySpEpsia rikkuNshiTo
NCT06482671 ·Status: RECRUITING ·Phase: PHASE3